TETRALOGIC PHARMACEUTICALS C - COM (TLOG)

CUSIP: 88165U109

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
6,298,080
Share change
-174,736
Total reported value
$14,733,000
Price per share
$2.34
Number of holders
32
Value change
-$2,015,224
Number of buys
18
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 88165U109?
CUSIP 88165U109 identifies TLOG - TETRALOGIC PHARMACEUTICALS C - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRALOGIC PHARMACEUTICALS C - COM (TLOG) as of Q2 2015

As of 30 Jun 2015, TETRALOGIC PHARMACEUTICALS C - COM (TLOG) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,298,080 shares. The largest 10 holders included Clarus Ventures, LLC, First Eagle Investment Management, LLC, First Washington CORP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, LAZARD ASSET MANAGEMENT LLC, Alyeska Investment Group, L.P., GEODE CAPITAL MANAGEMENT, LLC, Catalyst Capital Advisors LLC, and MORGAN STANLEY. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.